TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations
Conditions: Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations; Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations Intervention: Drug: TAS-117 Sponsor: Taiho Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials